VAXXINOVA NORWAY AS

5006 BERGEN

Finances

Share Ownership

Return on Equity

−2 302,67 %

Current Ratio

3,02

Debt-to-Equity Ratio

29,02

Key figures (NOK)	2022	2021	2020	2019
Revenue	10 427 000	8 510 000	36 550 000	34 794 000
Net Income	−12 941 000	−17 224 000	−12 176 000	−6 706 000
Total Assets	20 628 000	29 530 000	29 090 000	37 587 000
Total Equity	562 000	13 503 000	1 345 000	7 030 000

Income (NOK)	2022	2021	2020	2019
Revenue	10 427 000	8 510 000	36 550 000	34 794 000
Expenditure	27 119 000	30 547 000	51 996 000	42 675 000
Operating Profit	−16 692 000	−22 036 000	−15 447 000	−7 880 000
Financial Income	82 000	262 000	398 000	0
Financial Costs	88 000	304 000	877 000	737 000
Financial Balance	−6 000	−42 000	−479 000	−737 000
Earnings Before Tax	−16 698 000	−22 078 000	−15 927 000	−8 617 000
Tax	−3 757 000	−4 854 000	−3 751 000	−1 911 000
Net Income	−12 941 000	−17 224 000	−12 176 000	−6 706 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	9 271 000	2 234 000	12 616 000	13 135 000
Total Current Assets	11 357 000	27 296 000	16 474 000	24 452 000
Total Assets	20 628 000	29 530 000	29 090 000	37 587 000
Total Retained Equity	−24 627 000	−11 686 000	−23 844 000	−11 668 000
Total Equity	562 000	13 503 000	1 345 000	7 030 000
Total Long-Term Debt	16 311 000	12 968 000	12 810 000	12 558 000
Total Current Debt	3 755 000	3 058 000	14 935 000	17 999 000
Total Equity and Debt	20 628 000	29 530 000	29 090 000	37 587 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	10 427 000	8 510 000	36 550 000	34 794 000
Other Income	0	0	0	0
Revenue	10 427 000	8 510 000	36 550 000	34 794 000
Cost of Goods Sold	4 431 000	5 000 000	16 703 000	11 658 000
Salary Costs	13 116 000	14 441 000	18 199 000	17 161 000
Depreciation	916 000	1 384 000	2 951 000	2 698 000
Impairment	0	0	0	0
Expenditure	27 119 000	30 547 000	51 996 000	42 675 000
Operating Profit	−16 692 000	−22 036 000	−15 447 000	−7 880 000
Financial Income	82 000	262 000	398 000	0
Financial Costs	88 000	304 000	877 000	737 000
Financial Balance	−6 000	−42 000	−479 000	−737 000
Dividends	0	0	0	0
Net Income	−12 941 000	−17 224 000	−12 176 000	−6 706 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	3 598 000	0	3 274 000	1 354 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	2 229 000	2 180 000	9 341 000	11 781 000
Total Tangible Assets	2 229 000	2 180 000	9 341 000	11 781 000
Total Fiancial Fixed Assets	3 444 000	54 000	0	0
Total Fixed Assets	9 271 000	2 234 000	12 616 000	13 135 000
Stock	0	0	1 905 000	750 000
Total Investments	0	0	0	0
Cash, Bank	2 093 000	2 405 000	3 512 000	3 265 000
Total Current Assets	11 357 000	27 296 000	16 474 000	24 452 000
Total Assets	20 628 000	29 530 000	29 090 000	37 587 000
Total Equity	562 000	13 503 000	1 345 000	7 030 000
Short-Term Group Debt	135 000	605 000	9 795 000	9 296 000
Total Long-Term Debt	16 311 000	12 968 000	12 810 000	12 558 000
Creditors	1 007 000	449 000	2 099 000	2 834 000
Unpaid Taxes	669 000	724 000	2 203 000	2 076 000
Dividends	0	0	0	0
Other Current Debt	1 944 000	1 280 000	838 000	3 793 000
Total Current Debt	3 755 000	3 058 000	14 935 000	17 999 000
Total Equity and Debt	20 628 000	29 530 000	29 090 000	37 587 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−2 302,67 %	−127,56 %	−905,28 %	−95,39 %
Debt-to-Equity Ratio	29,02	0,96	9,52	1,79
Operating Profit Margin	−160,08 %	−258,94 %	−42,26 %	−22,65 %
Current Ratio	3,02	8,93	1,1	1,36
Quick Ratio	3,02	8,93	1,26	1,42
Equity Ratio	0,03	0,46	0,05	0,19
Gross Profit Margin	57,5 %	41,25 %	54,3 %	66,49 %